US National Cancer Institute Initiates Phase I Study of Treatment of Head and Neck Cancer Patients With Medivir’s Birinapant and Radiation Therapy_5d9eda804a9fe.jpeg e5118797b3f9f89090dce53bb927ab53 e5118797b3f9f89090dce53bb927ab53